Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 13/20 | 0.47 |
| ▸ | UBE2M | P61081 | 5/20 | 0.43 |
| ▸ | DCUN1D1 | Q96GG9 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CCR2 | P41597 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4565194 | 1.00 | TACR1 (0.47) | TACR1UBE2MDCUN1D1CYP3A4CYP2D6 | |
| SCHEMBL5943394 | 0.88 | TACR1 (0.59) | TACR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5943397 | 0.88 | TACR1 (0.59) | TACR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL6380364 | 0.88 | TACR1 (0.59) | TACR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4474037 | 0.81 | TACR1 (0.58) | TACR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4474027 | 0.81 | TACR1 (0.58) | TACR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4474033 | 0.81 | TACR1 (0.58) | TACR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4483142 | 0.80 | TACR1 (0.67) | TACR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4483139 | 0.80 | TACR1 (0.67) | TACR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4483149 | 0.80 | TACR1 (0.67) | TACR1CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622487-B2 | Piperidine derivative, process for producing the same, and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-11-24 | — | — | US | disclosed |